Influence of serum protein and albumin addition on the structure and activity of an exogenous pulmonary surfactant

Respiratory Physiology and Neurobiology

Volumn 175, Issue 3, 2011, Pages 316-321

  Martínez Sarrasague, María ^a   Cimato, Alejandra ^a   Rubin de Celis, Emilio ^a   Facorro, Graciela ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Albumin; Dynamic surface properties; Exogenous pulmonary surfactant; Serum proteins; Surfactant subtypes; Viscosity

Indexed keywords

ALBUMIN; LUNG SURFACTANT; PLASMA PROTEIN;

ARTICLE; PRIORITY JOURNAL; SURFACE PROPERTY; SURFACE TENSION; SUSPENSION; VISCOSITY;

ANIMALS; BLOOD PROTEINS; CATTLE; HUMANS; PULMONARY SURFACTANTS; SERUM ALBUMIN; SURFACE TENSION; VISCOSITY;

EID: 79751535404     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.12.009     Document Type: Article

References (35)

1. Ainsworth S.B., Milligan D.W. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review. Am. J. Respir. Med. 2002, 1(6):417-433.
2. Blanco O., Pérez-Gil J. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant. Eur. J. Pharmacol. 2007, 568(1-3):1-15.
3. Braun A., Stenger P.C., Warriner H.E., Zasadzinski J.A., Lu K.W., Taeusch H.W. A freeze-fracture transmission electron microscopy and small angle X-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure. Biophys. J. 2007, 93(1):123-139.
4. Clements J.A., Avery M.E. Lung surfactant and neonatal respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1998, 157(4 Pt 2):S59-66.
5. Creuwels L.A., van Golde L.M., Haagsman H.P. The pulmonary surfactant system: biochemical and clinical aspects. Lung 1997, 175:1-39.
6. Dargaville P.A., Mills J.F. Surfactant therapy for meconium aspiration syndrome: current status. Drugs 2005, 65:2569-2591.
7. do Campo J.L., Turchetto E., Bertranou E.G., Hager A.A., De Paoli T. Natural surfactant aerosolisation in adult respiratory distress syndrome. Lancet 1994, 344(8919):413-414.
8. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol. 1977, 43:198-203.
9. Fernsler J.G., Zasadzinski J.A. Competitive adsorption: a physical model for lung surfactant inactivation. Langmuir 2009, 25(14):8131-8143.
10. Finer N.N. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatr. Respir. Rev. 2004, 5:289-297.
11. Gross N., Kellam M., Young J., Krishnasamy S., Dhand R. Separation of alveolar surfactant into subtypes A comparison of methods. Am. J. Respir. Crit. Care Med. 2000, 152:517-522.
12. Günther A., Ruppert C., Schmidt R., Markart P., Grimminger F., Walmrath D., Seeger W. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir. Res. 2001, 2(6):353-364.
13. Hager, A., De Paoli, T., 2001. Method for extracting and purifying pulmonary surfactant. United States patent US 6172203 B1, January.
14. King D.M., Wang Z., Kendig J.W., Palmer H.J., Holm B.A., Notter R.H. Concentration-dependent, temperature-dependent non-Newtonian viscosity of lung surfactant dispersions. Chem. Phys. Lipids 2001, 112(1):11-19.
15. King D.M., Wang Z., Palmer H.J., Holm B.A., Notter R.H. Bulk shear viscosities of endogenous and exogenous lung surfactants. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:277-284.
16. Larsson M., Nylander T., Keough K.M., Nag K. An X-ray diffraction study of alterations in bovine lung surfactant bilayer structures induced by albumin. Chem. Phys. Lipids 2006, 144(2):137-145.
17. Lauer S., Fischer L.G., Stubbe H.D., Van Aken H., Westphal M. Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome. Anaesthesist 2006, 55:433-442.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin Phenol Reagent. J. Biol. Chem. 1951, 193:265-275.
19. Lu K.W., William Taeusch H., Robertson B., Goerke J., Clements J.A. Polymer-surfactant treatment of meconium-induced acute lung injury. Am. J. Respir. Crit. Care Med. 2000, 162:623-628.
20. Lu K.W., Pérez-Gil J., Taeusch H.W. Kinematic viscosity of therapeutic pulmonary surfactants with added polymers. Biochim. Biophys. Acta 2009, 1788(3):632-637.
21. Maitra G., Inchley K., Novick R.J., Veldhuizen R.A., Lewis J.F., Possmayer F. Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282(1):67-74.
22. Nag K., Hillier A., Parsons K., Garcia M.F. Interactions of serum with lung surfactant extract in the bronchiolar and alveolar airway models. Respir. Physiol. Neurobiol. 2007, 157(2-3):411-424.
23. Otsubo E., Takei T. Characterization of the surface activity of a synthetic surfactant with albumin. Biol. Pharm. Bull. 2002, 25(12):1519-1523.
24. Playfor S.D., Nootigattu V.K. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome. Curr. Drug Saf. 2006, 1(2):159-168.
25. Poulain F.R., Clements J.A. Pulmonary surfactant therapy. West J. Med. 1995, 162(1):43-50.
26. Ramanathan R. Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials. J. Perinatol. 2009, 29(Suppl. 2):S38-43.
27. Ramanathan R. Choosing a right surfactant for respiratory distress syndrome treatment. Neonatology 2009, 95(1):1-5.
28. Seeger W., Grube C., Günther A., Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur. Respir. J. 1993, 6(7):971-977.
29. Stewart J.C.M. Colorimetric determination of phospholipids with Ammonium Ferrothiocyanate. Analyt. Biochem. 1980, 104:10-14.
30. Taeusch H.W., de la Serna J.B., Perez-Gil J., Alonso C., Zasadzinski J.A. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental. Biophys. J. 2005, 89(3):1769-1779.
31. Taut F.J., Rippin G., Schenk P., Findlay G., Wurst W., Häfner D., Lewis J.F., Seeger W., Günther A., Spragg R.P. A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest 2008, 134:724-732.
32. Ueda T., Ikegami M., Jobe A. Surfactant subtypes in vitro conversion, in vivo function, and effects of serum proteins. Am. J. Respir. Crit. Care Med. 1994, 149:1254-1259.
33. Veldhuizen R.A., Inchley K., Hearn S., Lewis J.F., Possmayer F. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem. J. 1993, 295:141-147.
34. Veldhuizen R.A., Marcou J., Yao L.J., Ito Y., Lewis J.F. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am. J. Physiol. 1996, 270:152-158.
35. Wagner N.J., Woutersen A.T.J.M. The viscosity of bimodal and polydisperse suspensions of hard spheres in the dilute limit. J. Fluid Mech. 1994, 278:267-287.